Planned enrollment increased by 274 participants
Before: 476 participants (planned). After: 750 participants (planned).
Primary completion date changed
Before: 31 May 2028. After: 21 May 2031.
Study sponsor: Vera Therapeutics, Inc. · VERA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 476 participants (planned). After: 750 participants (planned).
Before: 31 May 2028. After: 21 May 2031.